July 10, 2025: Bengaluru-based supply chain automation startup Arteria Technologies has raised ₹100 crore in a Series B round led by ICICI Venture, aiming to scale its AI-powered SaaS platform, expand into new markets, and accelerate product innovation.
The fresh round of capital raised through a combination of primary and secondary funding, will be deployed to foray into new markets, consolidate its human resources, and drive AI innovation across its platform.
Arteria Funding to Power Team Expansion, Market Entry, and Data-Led Supply Chain Intelligence
Sriram Kanuri, Chief Executive Officer of Arteria, stated “This funding will play a key role in growing our team, entering new markets, and investing in AI-led product innovation,” He added, We are committed to using data intelligence to improve supply chain visibility for our enterprise clients and unlock easy, tech-enabled financing for supply chain partners.”
Arteria founded in Bengaluru in the year 2010, provides digital solutions for managing upstream and downstream enterprise supply chains, with embedded financing options aimed at improving capital flow for suppliers and distributors. The company revealed it serves more than 100 large enterprises across sectors such as FMCG, automotive, building materials and process manufacturing.
“Arteria’s fast-growing, profitable path as a software products SaaS company stands out in the Indian IT market,” said Sharad Malpani, Director at ICICI Venture and co-head of IVen Amplifi Fund, which led the round.
“Its tech-focused, data-driven approach to digitising supply chains, combined with Arteria’s ability to integrate financing solutions from third parties seamlessly, offers a strong value proposition for many companies in India, especially in the MSME sector.” Malpani added.
Previously, ICICI Bank and its unit ICICI Investment Management Co. had each picked up 9.99% in the fintech SaaS startup for Rs 8.68 crore in cash in the year 2018. Based in Mumbai, ICICI Venture is an Indian private equity firm that was established in 1988 as a subsidiary of ICICI Bank. It primarily invests in mid-market businesses offer growth equity to help companies enhance operations and solidify their market position.
Innovist, the company behind personal care brands including Bare Anatomy and Chemist at Play, recently raised Rs 136 crore in a Series B funding round led by ICICI Venture through its new early growth fund, IVen Amplifi, marking its first investment.
The latest round of funding was raised from from ICICI Venture.
